HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat

Publisher： John Wiley & Sons Inc

E-ISSN： 2056-4538|2|2|59-71

ISSN： 2056-4538

Source： The Journal Of Pathology: Clinical Research, Vol.2, Iss.2, 2016-04, pp. : 59-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib

By Mechtersheimer Gunhild  

Virchows Archiv, Vol. 444, Iss. 2, 2004-02 ,pp. : 108-118

Springer Publishing Company

Access to resources Recommend Favorite

Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases

By  

Current Stem Cell Research & Therapy, Vol. 9, Iss. 6, 2014-11 ,pp. : 513-521

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Unengineered and Engineered Wharton’s Jelly Mesenchymal Stem Cells as Cancer Inhibitor Agent

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 15, Iss. 2, 2015-08 ,pp. : 128-10

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

By Ali Husham   Abdullah Zainalabideen  

Journal of Immunotoxicology, Vol. 5, Iss. 2, 2008-04 ,pp. : 173-177

Informa Healthcare

Access to resources Recommend Favorite

Differential Gene Expression in Apoptosis: Identification of Ribosomal Protein 23K, a Cell Proliferation Inhibitor

By Chen F.W.   Davies J.P.   Ioannou Y.A.  

Molecular Genetics and Metabolism, Vol. 64, Iss. 4, 1998-08 ,pp. : 271-282

Academic Press

Access to resources Recommend Favorite